Access Official Technical PDF

Share Summary:LinkedInEmail

Questions about 5G health effects matter to organizations planning wireless infrastructure for plants, campuses and other industrial environments. A 2019 New Hampshire commission meeting reviewed findings from the U.S. National Toxicology Program (NTP) on radiofrequency radiation (RFR) and considered how those results relate to newer wireless technologies. The key distinction for technical decision-makers is that the NTP studies examined 2G and 3G signals—not 5G—and their animal findings cannot be directly translated into human health risks.

What the NTP studies examined

The NTP, an interagency program established in 1978, evaluates substances and exposures of public health concern using toxicology and other biological research. The U.S. Food and Drug Administration nominated wireless-device RFR for study in 1999. Researchers faced a practical challenge: creating controlled, measurable exposures that could be applied consistently to laboratory animals.

For the studies, the NTP used shielded reverberation chambers. Antennas distributed radiofrequency signals within the chambers, allowing researchers to monitor and control exposure conditions. Rats and mice were exposed to GSM and CDMA signals associated with 2G and 3G technologies. The study program included short-term and longer-term phases, with exposure periods alternating on and off.

These methods made it possible to study defined exposure scenarios under laboratory conditions. They did not reproduce every feature of everyday wireless use, such as a person’s position relative to a transmitting device, varied background signals, or changing patterns of exposure.

What the animal results reported

At the meeting, NTP scientists summarized their findings using the program’s four-level evidence scale: no evidence, equivocal evidence, some evidence and clear evidence. The reported results varied by species, sex, tissue and outcome.

  • Male rats: The NTP reported clear evidence of malignant schwannomas in the heart. It reported some evidence of malignant gliomas in the brain and pheochromocytomas in the adrenal gland.
  • Other findings: The studies also reported DNA damage in some tissues and equivocal evidence of carcinogenic activity in mice. The meeting summary noted findings related to lower body weight in exposed offspring.

“Clear evidence” and “some evidence” are classifications used to describe results in the NTP’s animal cancer studies. As the presenters explained, these labels do not quantify risk in people or predict how often a health outcome might occur in a human population.

Why the results do not answer the 5G question

The NTP reports were based on 2G and 3G signals. They were not tests of 5G networks, equipment or deployment patterns. The meeting discussion identified further research as necessary to address newer technologies, including different signal characteristics and frequencies. Presenters also noted that 5G exposure scenarios could be difficult to reproduce using the facilities and methods available at the time.

Several limitations are important when interpreting the findings:

  • Animal studies are not human exposure studies. The researchers cautioned against directly extrapolating the results to typical cell phone use. Animals experienced whole-body exposure under controlled conditions, unlike the more localized exposure associated with holding a phone near the head.
  • Exposure levels and conditions matter. The meeting included discussion of the study’s exposure levels and the relationship between device limits and actual exposure. The presenters emphasized that exposure depends on factors such as distance, power and how a person is positioned relative to an antenna.
  • Research questions remain open. Proposed follow-up work included studying newer technologies, investigating biological mechanisms and DNA repair, and evaluating biomarkers of exposure. Cumulative and combined exposures were also discussed as challenging areas for further study.

The meeting record also captures differing interpretations of the wider evidence. Some participants raised concerns about possible biological effects, while others stressed the difficulty of applying animal results to people. Those comments reflect the discussion; they should not be mistaken for additional NTP conclusions.

What industrial decision-makers should take from the discussion

For plant managers, system integrators and automation engineers, the practical lesson is to separate established study findings from unanswered questions. The NTP results are relevant to understanding research on 2G and 3G RFR in laboratory animals, but they do not establish the health effects of 5G or determine the risk associated with a particular industrial wireless installation.

When evaluating wireless projects, decision-makers can keep the technical conversation grounded by documenting the system under consideration and the assumptions behind any exposure assessment. Relevant details include the technology and signal types involved, equipment locations, operating conditions and how exposure is measured or estimated. Where health questions arise, consult applicable regulatory guidance and qualified technical or occupational health professionals rather than treating animal-study classifications as direct measures of human risk.

Conclusion

The 2019 commission discussion illustrates both the value and the limits of the NTP’s cell phone RFR research. The studies reported specific findings in rats and mice exposed to 2G and 3G signals, but they were not designed to establish human risk or assess 5G. For industrial organizations adopting wireless connectivity, careful interpretation, transparent exposure assumptions and continued research are more useful than drawing conclusions beyond the evidence available.

Access Official Technical PDF

About The Author